superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2024-12-31
- Valid until
- 2025-12-31
- Published
- 2025-01-31
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 17,644,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Novartis operating income: 14,544,000,000 United States dollar", as of 2024-12-31 (until 2025-12-31). Claim clm_2DD252AFDAA3, https://asof.is/claim/clm_2DD252AFDAA3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.
APA
AsOf. (2024). Novartis operating income: 14,544,000,000 United States dollar (as of 2024-12-31 (until 2025-12-31)) [Record clm_2DD252AFDAA3]. Retrieved November 8, 2026, from https://asof.is/claim/clm_2DD252AFDAA3 (source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm)
BibTeX
@misc{asof_clm_2DD252AFDAA3,
author = {AsOf},
title = {Novartis operating income: 14,544,000,000 United States dollar},
year = {2024},
howpublished = {\url{https://asof.is/claim/clm_2DD252AFDAA3}},
note = {Claim clm\_2DD252AFDAA3, as of 2024-12-31 (until 2025-12-31); source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_2DD252AFDAA3.md/v1/claims/clm_2DD252AFDAA3submit a correction